Evidence map›Paper›PMID 40004020›Full record

ArticleInternational journal of molecular sciences2025

Enhanced Anti-Cancer Potential: Investigating the Combined Effects with

Tomasz Jędrzejewski, Justyna Sobocińska, Bartosz Maciejewski, Marcela Slovakova, Sylwia Wrotek

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomasz JędrzejewskiDepartment of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska 1 Str., 87-100 Toruń, Poland.ORCID 0000-0001-8950-5643
Justyna SobocińskaDepartment of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska 1 Str., 87-100 Toruń, Poland.ORCID 0000-0003-4640-9533
Bartosz MaciejewskiDepartment of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska 1 Str., 87-100 Toruń, Poland.ORCID 0000-0003-3496-8805
Marcela SlovakovaDepartment of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573 Str., 532 10 Pardubice, Czech Republic.ORCID 0000-0002-4975-0983
Sylwia WrotekDepartment of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska 1 Str., 87-100 Toruń, Poland.ORCID 0000-0001-8744-7822

Funding

Nicolaus Copernicus University "Excellence Initiative - Research University" program (Mobility for employees, 9th edition)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsChromonesMorpholinesNeoplasmsPhosphoinositide-3 Kinase InhibitorsPlant ExtractsApoptosisCell Line, TumorCell MovementCell ProliferationCell SurvivalDrug SynergismHeLa CellsHumansMCF-7 CellsPhosphatidylinositol 3-Kinases2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAntineoplastic AgentsChromonesMorpholinesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPlant ExtractscancerCoriolus versicolorLY294002phosphatidylinositol 3-kinase

Identifiers

PMID40004020
PMCPMC11855823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.